To understand the potential mechanism by which apelin/APLNR affects the progression of MASLD, we first investigated the direct effects of apelin and APLNR on hepatic lipid accumulation. The gene discussed is APLNR; the disease is metabolic dysfunction-associated steatotic liver disease.